Competing interests
N.O.G.
The authors report the following general conflicts. E.L.G. has no conflicts related to the present study but has received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, MSD, Novo Nordisk, Lundbeck Pharma and Organon. He is serving as investigator in clinical studies sponsored by AstraZeneca, Idorsia, and Bayer and has received unrestricted research grants from Boehringer Ingelheim. T.S., J.K., N.B.N., N.O.G., L.N.L., S.D.K., A.M.H., and M.M. have no competing interests to declare.